BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sui B, Cheng C, Shi S, Wang M, Xu P. Esterase-activatable and GSH-responsive Triptolide Nano-prodrug for the Eradication of Pancreatic Cancer. Adv Nanobiomed Res 2021;1:2100040. [PMID: 34870282 DOI: 10.1002/anbr.202100040] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Hong T, Shen X, Syeda MZ, Zhang Y, Sheng H, Zhou Y, Xu J, Zhu C, Li H, Gu Z, Tang L. Recent advances of bioresponsive polymeric nanomedicine for cancer therapy. Nano Res 2022. [DOI: 10.1007/s12274-022-5002-2] [Reference Citation Analysis]
2 He X, Wang N, Zhang Y, Huang X, Wang Y. The therapeutic potential of natural products for treating pancreatic cancer. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1051952] [Reference Citation Analysis]